THE BIOTECHNOLOGY INCUBATOR AT NYMC INC (EIN 471682208) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

ROBERT W AMLER

Phone

9145941000

Tax Period

2024-07-01 to 2025-06-30

THE BIOTECHNOLOGY INCUBATOR AT NYMC INC, founded in 2014, is a small nonprofit in the Community Improvement sector that reported $224K in total revenue in fiscal year 2024. Revenue surged 33% from the prior year, signaling strong growth momentum. The organization ran a surplus of $72K, a strong 32% operating margin.

Mission

TO STIMULATE THE ESTABLISHMENT AND GROWTH OF NUMEROUS BIOTECHNOLOGY START-UP COMPANIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $223,804

Investment Income $0

Other Revenue $0

TOTAL REVENUE $223,804

Expense Breakdown

Grants Paid $0

Salaries & Benefits $120,375

Fundraising Expenses $3,107

Program Expenses $123,326

Other Expenses $31,092

TOTAL EXPENSES $151,467

Year-over-Year Comparison

	2024	2023	Change
Revenue	$223,804	$167,871	+0.3%
Expenses	$151,467	$141,580	+0.1%
Net Income	$72,337	$26,291	+1.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$2,572,255

Total Directors

$2,609,534

Key Employees

$722,091

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
EDWARD C HALPERIN	CHANCELLOR OF HEALTH AFF & CEO	0.10	Officer Director	$0	$72,639	$772,771
ROBERT W AMLER	DEAN SHSP	0.10	Director	$0	$49,578	$474,798
ALAN KADISH	PRESIDENT & TRUSTEE	0.10	Officer Director	$0	$249,801	$1,361,965
HOWARD BARUCH	DIRECTOR	0.10	Director	$0	$0	$0
NICHOLAS JANIGA	VP, CHIEF COUNSEL & ASST SECRETARY	0.10	Officer	$0	$82,122	$437,519
SALOMON AMAR	MEDICAL DIRECTOR	0.10	Key Emp	$0	$115,083	$722,091

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$223,804	$151,467	$2,059,059	$72,337
2024	$167,871	$141,580	$1,982,085	$26,291
2023	$389,283	$167,137	$1,958,931	$222,146
2022	$604,155	$130,605	$1,745,060	$473,550
2021	$585,213	$99,680	$1,274,885	$485,533
2020	$335,743	$236,618	$776,390	$99,125
2019	$749,509	$327,242	$676,765	$422,267
2018	$375,773	$418,637	$249,610	$-42,864

THE BIOTECHNOLOGY INCUBATOR AT NYMC INC